Lack of ethical, legal, and clinical consensus about best practice sometimes combines with a poor clinical evidence base.

Poor oral health has been neglected as a public health threat, despite recognition as “epidemic” in scale by the US Office of the Surgeon General.

Long-acting injectables powerfully augment HIV care, but broad acceptance and uptake could be compromised by what we know about experiences with antipsychotics.

Ending AIDS requires normalizing justice-based approaches to HIV care and acknowledging how power dynamics shape popular narratives and practices.

Merits and drawbacks of U = U messaging are ethically and clinically complex, and drawbacks could harm patients in whom viral suppression is hard to achieve.

Financial incentives have been shown to improve antiretroviral adherence for people living with HIV, but some say offering them commodifies HIV care.

Drs Oliva Kates and Monica Gandhi join Ethics Talk to discuss equity and public health messaging in ending the HIV epidemic.

Information different patients need or want about cybersecurity risk varies, so communicating clearly is always key.

A history of device oversight by the US Food and Drug Administration traces regulatory changes in response to injuries caused by Dalkon Shield intrauterine devices.

Once focused on hospital liability, risk managers now navigate a broader set of enterprise risk management responsibilities.